ICD-10 Coding for Anemia in Neoplastic Disease(D63.0, D63.0A, D63.0B)
Learn about ICD-10 coding for anemia in neoplastic disease, including code D63.0 for malignancy-related anemia and D64.81 for chemotherapy-induced anemia.
Complete code families applicable to Anemia in Neoplastic Disease
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D63.0 | Anemia in neoplastic disease | Use when anemia is directly caused by the malignancy itself. |
|
| D64.81 | Anemia due to antineoplastic chemotherapy | Use when anemia is a direct result of chemotherapy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAnemia in Neoplastic Disease
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Anemia in Neoplastic Disease.
Vague documentation of anemia
Impact
Clinical: May lead to inappropriate treatment., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.
Mitigation
Educate providers on specific documentation requirements, Use standardized templates
Using D63.0 for chemotherapy-induced anemia
Impact
Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Use D64.81 for anemia due to chemotherapy.
Incorrect Code Sequencing
Impact
Improper sequencing of anemia and neoplasm codes.
Mitigation
Regular training on ICD-10 sequencing rules.